Cargando…

Control of multidrug-resistant organisms

Detalles Bibliográficos
Autor principal:	Raine, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	South African Medical Association 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278996/ https://www.ncbi.nlm.nih.gov/pubmed/34286244 http://dx.doi.org/10.7196/AJTCCM.2019.v25i1.009

Ejemplares similares

Isolation strategy for controlling the spread of multidrug-resistant organisms: Is this still an essential option in hospitals?
por: Larrosa, María Nieves, et al.
Publicado: (2021)

Isolation strategy for controlling the spread of multidrug-resistant organisms: Is this still an essential option in hospitals?
por: Larrosa, María Nieves, et al.
Publicado: (2021)

Spread of Multidrug-Resistant Microorganisms
por: Di Lodovico, Silvia, et al.
Publicado: (2022)

Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms
por: Jorgensen, Sarah C. J., et al.
Publicado: (2018)

Fluoroquinolone resistance in multidrug-resistant tuberculosis patients
por: Lee, Hyun-Woo, et al.
Publicado: (2019)

Multidrug Resistance: The Growing Menace in PICU
por: Kamath, Shrishu R
Publicado: (2023)

Predictors of Treatment Success for Multidrug Resistant Tuberculosis
por: Park, Sang Won
Publicado: (2016)

Editorial for Special Issue “Multidrug-Resistant Pathogens”
por: Koulenti, Despoina, et al.
Publicado: (2020)

Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis
por: Parums, Dinah V.
Publicado: (2021)

Special Issue “Multidrug-Resistant Bacteria in the Environment, Their Resistance and Transfer Mechanisms”
por: Grohmann, Elisabeth
Publicado: (2023)

Stewardship of Antibiotics for Multidrug-Resistant Gram-Negative Bacteria
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel
por: Lange, Christoph, et al.
Publicado: (2022)

Multidrug Resistance in Critically Ill Patients: An Unresolved Issue
por: Spadaro, Savino
Publicado: (2023)

Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study
por: Mascitti, Hélène, et al.
Publicado: (2018)

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collection
por: Gottesman, Michael M., et al.
Publicado: (2023)

Burden of multidrug-resistant organisms in Hungary
por: Szilágyi, E, et al.
Publicado: (2011)

Importance of Public-Private Mix Collaboration in Tuberculosis Control: It Is Also Valuable in Patients with Multidrug-Resistant Tuberculosis
por: Kwon, Yong-Soo
Publicado: (2021)

Prevention of Multidrug-Resistant Tuberculosis in Close Contacts. Back to the Future?
por: Schluger, Neil W.
Publicado: (2020)

Multidrug-resistant organisms in refugees: prevalences and impact on infection control in hospitals
por: Heudorf, Ursel, et al.
Publicado: (2016)

State of the Globe: The Rippling Effect of Multidrug-Resistant Gram-negative Infections
por: Baluch, Aliyah
Publicado: (2015)

Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera
por: Varela, Manuel F., et al.
Publicado: (2013)

Multidrug-resistant tuberculosis: diagnosis, checklists, adverse events, advice and outcomes
por: Bothamley, Graham H.
Publicado: (2022)

Natural Product-Derived Compounds for Targeting Multidrug Resistance in Cancer and Microorganisms
por: U. Ferreira, Maria-José
Publicado: (2023)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
por: Lee, Nan-Yao, et al.
Publicado: (2019)

Burden and Management of Multidrug-Resistant Organisms in Palliative Care
por: Datta, Rupak, et al.
Publicado: (2017)

Efficacy of Infection Control Interventions in Reducing the Spread of Multidrug-Resistant Organisms in the Hospital Setting
por: D'Agata, Erika M. C., et al.
Publicado: (2012)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification
por: Falcone, Marco, et al.
Publicado: (2021)

Multidrug resistance associated proteins in multidrug resistance
por: Sodani, Kamlesh, et al.
Publicado: (2012)

New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic
por: Oliva, Alessandra, et al.
Publicado: (2018)

Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015
por: Latour, Katrien, et al.
Publicado: (2019)

Multidrug-resistant Organisms in Hospitals: What Is on Patient Hands and in Their Rooms?
por: Mody, Lona, et al.
Publicado: (2019)

Influx of multidrug-resistant organisms by country-to-country transfer of patients
por: Mutters, Nico T., et al.
Publicado: (2015)

Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Multidrug-resistant organisms (MDROs) in patients with subarachnoid hemorrhage (SAH)
por: Rhim, Ha-Young, et al.
Publicado: (2021)

Multidrug-resistant organisms in lung transplant: a narrative review
por: Congedi, Sabrina, et al.
Publicado: (2023)

Community-onset bloodstream infection with multidrug-resistant organisms: a matched case-control study
por: Lim, Ching Jou, et al.
Publicado: (2014)

Editorial on the Special Issue: “Multidrug Combinations”
por: Vale, Nuno
Publicado: (2022)

Can the Prevalence of Symptoms in Patients with Inflammatory Bowel Disease be Predicted by the Analysis of Multidrug Resistance Gene 1 Polymorphisms?
por: Chiurillo, Miguel Angel
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6j1or8bmqjmtktjgcq24criho2